GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

AVE Science & Technology Co 688067.SS · CNY

Health Care · Shanghai · 🇨🇳 China

Compare

19.93

-0.94%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥230.0m

FY2016FY2025

Net income

CN¥28.9m

FY2016FY2025

Free cash flow

CN¥38.3m

FY2016FY2025

Shareholders' equity

CN¥514.4m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥230.0mCN¥203.3mCN¥200.3mCN¥196.8mCN¥210.7mCN¥180.2mCN¥190.0mCN¥150.5mCN¥135.6mCN¥117.1m
Research and developmentCN¥27.3mCN¥25.4mCN¥27.7mCN¥33.1mCN¥31.2mCN¥22.6mCN¥20.5mCN¥19.2mCN¥12.6m—
Operating incomeCN¥30.1mCN¥23.6mCN¥22.4mCN¥18.5mCN¥34.2mCN¥34.4mCN¥57.5mCN¥30.2mCN¥30.8mCN¥22.0m
Net incomeCN¥28.9mCN¥22.8mCN¥21.5mCN¥18.0mCN¥31.3mCN¥30.1mCN¥50.5mCN¥27.3mCN¥27.4mCN¥30.3m
Diluted earnings per share0.440.350.340.250.490.571.000.540.530.60

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥580.1mCN¥561.0mCN¥556.7mCN¥549.7mCN¥547.6mCN¥296.6mCN¥297.4mCN¥257.7mCN¥224.1mCN¥211.4m
Cash and short-term investments—CN¥71.6mCN¥87.8mCN¥277.5mCN¥293.3mCN¥59.8mCN¥33.5mCN¥43.0mCN¥24.5mCN¥47.8m
Total liabilitiesCN¥65.8mCN¥65.2mCN¥66.8mCN¥74.5mCN¥70.0mCN¥59.9mCN¥44.9mCN¥40.4mCN¥34.1mCN¥33.5m
Shareholders' equityCN¥514.4mCN¥495.8mCN¥489.8mCN¥475.1mCN¥477.6mCN¥236.7mCN¥252.5mCN¥217.3mCN¥189.9mCN¥177.8m
Shares outstanding65m65m63m72m64m53m51m50m52m51m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥41.5mCN¥22.4mCN¥22.7mCN¥29.7mCN¥47.2mCN¥46.9mCN¥62.1mCN¥40.4mCN¥24.8mCN¥31.2m
Capital spending−CN¥3.2m−CN¥3.8m−CN¥4.5m−CN¥21.2m−CN¥20.5m−CN¥11.8m−CN¥24.5m−CN¥17.4m−CN¥48.1m−CN¥22.5m
Free cash flowCN¥38.3mCN¥18.7mCN¥18.2mCN¥8.5mCN¥26.7mCN¥35.1mCN¥37.6mCN¥23.0m−CN¥23.3mCN¥8.7m
Dividends paid−CN¥10.4m−CN¥6.8m−CN¥6.8m−CN¥20.4m—−CN¥45.9m−CN¥15.3m—−CN¥10.2m—

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥60.2mCN¥53.0mCN¥59.1mCN¥61.4mCN¥56.2mCN¥53.3mCN¥50.2mCN¥55.9m
Operating incomeCN¥9.8mCN¥7.0m−CN¥1.3mCN¥16.9mCN¥8.1mCN¥6.4m−CN¥3.6mCN¥15.1m
Net incomeCN¥10.3mCN¥7.4m−CN¥293,159CN¥15.2mCN¥7.7mCN¥6.3m−CN¥2.3mCN¥13.5m
Diluted earnings per share0.160.11-0.000.230.120.10-0.040.21
Cash from operations———CN¥15.0mCN¥10.0m—CN¥13.0m—
Capital spending—−CN¥1.0m——————
Total assetsCN¥632.4mCN¥615.0mCN¥580.1mCN¥611.5mCN¥598.5mCN¥558.9mCN¥561.0mCN¥553.6m
Cash and short-term investments———CN¥216.0mCN¥108.3mCN¥74.3mCN¥71.6mCN¥37.0m
Debt———CN¥30.0mCN¥30.0m———
Shareholders' equityCN¥525.3mCN¥521.9mCN¥514.4mCN¥518.4mCN¥503.2mCN¥502.1mCN¥495.8mCN¥499.5m

Financial ratios

Data as of 30 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2012
Operating margin13.1%11.6%11.2%9.3%16.1%18.6%——
Net margin12.6%11.2%10.8%9.1%14.8%16.7%——
Return on equity5.6%4.6%4.4%3.8%6.5%12.7%——
Return on assets5.0%4.1%3.9%3.3%5.7%10.1%——
Free cash flow yield3.5%2.0%2.2%3.6%5.3%5.6%——
Revenue growth13.1%1.5%1.8%-6.6%16.9%-5.1%——
Earnings growth26.7%6.1%19.8%-42.5%3.9%-40.4%——
Current ratio6.69x5.52x5.24x5.30x6.12x2.40x——
Debt to equity———————0.00x
Equity ratio88.7%88.4%88.0%86.4%87.2%79.8%——
Interest coverage151.47x—881.13x602.78x1973.24x1439.24x4192.25x—
R&D as a share of sales11.9%12.5%13.8%16.8%14.8%12.6%——
Buybacks as a share of market value-0.5%-3.8%13.1%-11.9%-22.0%-3.8%——

Growth per year

Compound annual rate

3 years5 years10 years
Revenue5.3%5.0%9.5%
Operating income17.6%-2.6%7.3%
Net income17.2%-0.8%1.7%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin12.4%11.4%13.4%16.7%
Net margin12.0%11.0%12.5%16.4%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings55.447.669.275.057.2
Price to sales7.05.37.46.88.5

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 8 Dec 2025.

FY2025FY2024FY2023FY2022
Paid in the year0.0540.100.100.30

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.